• Client Login
Ozmosi
  • Services
    • BEAM Clinical Trial Data
    • GCT Global Clinical Trials
    • PRYZM Pharma Product Database
    • PDUFA Calendar
    • KRYSTL Industry Scan Reporting
    • LENZ Company Pipeline Summary
    • Specialized Consulting
    • Approved Pharmaceutical Products in Use
  • About Us
  • Case Studies
  • Newsroom
  • Contact Us
Select Page

New Faces in Big Pharma & the Rise of the Billion Dollar Deal

Apr 21, 2025 | Business, Industry Trends

M&A mania is here. Unprecedented deal values for mergers and acquisitions dominated in 2014.  Worldwide M&A was up 47% since 2013 with 95 deals valued greater than $5 billion, as reported by Reuters. Most deals were transacted in the energy,...
Using NLP Data to Classify Patient Segments in Clinical Trial Data

Using NLP Data to Classify Patient Segments in Clinical Trial Data

Apr 21, 2025 | Industry Trends, New Technology

One of the most common and powerful approaches in NLP provides the content experts an opportunity to label each data segment for a portion of the dataset and then analyze these labels to apply to the rest of the dataset. Some key questions need to be answered when...
When Good Things DON’T Come to Those Who Wait: How Pharma Companies Compare in Governance Efficiency

When Good Things DON’T Come to Those Who Wait: How Pharma Companies Compare in Governance Efficiency

Apr 21, 2025 | Industry Trends, New Technology

Predicting when a competing product will be approved is essential in any commercial forecast and for any business insights team with their eye on the market.  Here at OZMOSI, we have been spending our summer building out a machine learning approach to further improve...

A Gift for Patients – Medicare to Cover Lung Cancer Screening

Apr 21, 2025 | Cancer, Industry Trends

LUNG CANCER SCREENING UPDATE: As of February 5, 2015, effective immediately, Medicare will cover lung cancer screening by low-dose CT. ORIGINAL POST – Dec. 1, 2014 The Centers for Medicare & Medicaid Services (CMS) recently issued a proposal for Medicare to cover...
Next Entries »

Recent Posts

  • 7 Small-Cap Biotech Companies to Watch at AACR in AprilMay 19, 2025
  • Tango Therapeutics: Early Stage Oncology Pipeline Comes Into Focus in AprilMay 19, 2025
  • How Next-Generation Probability of Success Forecasting Can Improve Clinical Trial Accuracy by 44%May 12, 2025
  • Market Overview: GLP-1 Agonists and the Obesity MarketMay 12, 2025
  • Not Your Grandparents’ Probability of Success ForecastsMay 5, 2025
  • Clinical Trial Success Rates: What Makes Some Companies Stand Out?May 5, 2025
  • Home
  • About Us
  • Services
  • Case Studies
  • Newsroom
  • Contact Us
  • Facebook
  • X
OZMOSI© 2024 | All Rights Reserved | Site by Webtyde